SecBot SecBot
SECBOTREPLAY Home › Report › FATE

FATE · Fate Therapeutics' universal shelf registration (S-3, File No

FATE THERAPEUTICS INC · EFFECT filed Nov 13, 2026 at 00:15 ET

At the news

BEARISHIMPACT 5/10

EFFECT filed Nov 13, 2026 at 00:15 ET

Fate Therapeutics' universal shelf registration (S-3, File No. 333-299862) became effective on November 12, 2026, enabling the company to sell up to $300M in securities including a $100M ATM facility. As a pre-revenue clinical-stage biotech with $139.1M cash and ongoing net losses, this effectiveness signals potential near-term dilution to fund pipeline development.

  • Shelf registration (File No. 333-299862) became effective on November 12, 2026
  • Shelf registers up to $300M in securities including a $100M ATM facility with Leerink Partners
  • Company had $139.1M cash as of September 30, 2026
  • Pre-revenue clinical-stage biotech with Q3 2026 net loss of $0.25 per share

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access